Shoichiro Ohta

6.9k total citations · 1 hit paper
130 papers, 4.6k citations indexed

About

Shoichiro Ohta is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Shoichiro Ohta has authored 130 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Physiology, 35 papers in Pulmonary and Respiratory Medicine and 31 papers in Immunology. Recurrent topics in Shoichiro Ohta's work include Asthma and respiratory diseases (43 papers), Respiratory and Cough-Related Research (15 papers) and IL-33, ST2, and ILC Pathways (14 papers). Shoichiro Ohta is often cited by papers focused on Asthma and respiratory diseases (43 papers), Respiratory and Cough-Related Research (15 papers) and IL-33, ST2, and ILC Pathways (14 papers). Shoichiro Ohta collaborates with scholars based in Japan, United States and Sweden. Shoichiro Ohta's co-authors include Kenji Izuhara, Junya Ono, Kazuhiko Arima, Uleng Bahrun, Kiyoshi Takatsu, Yoshinori Nagai, Karla P. Garrett, Taku Kouro, Shizuo Akira and Paul W. Kincade and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Immunity.

In The Last Decade

Shoichiro Ohta

128 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Toll-like Receptors on Hematopoietic Progenitor Cells Stimulate Innate Immune System Replenishment

2006 673 citations Shoichiro Ohta, Uleng Bahrun et al. profile →

Peers

Countries citing papers authored by Shoichiro Ohta

Since Specialization

Citations

This map shows the geographic impact of Shoichiro Ohta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoichiro Ohta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoichiro Ohta more than expected).

Fields of papers citing papers by Shoichiro Ohta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoichiro Ohta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoichiro Ohta. The network helps show where Shoichiro Ohta may publish in the future.

Co-authorship network of co-authors of Shoichiro Ohta

This figure shows the co-authorship network connecting the top 25 collaborators of Shoichiro Ohta. A scholar is included among the top collaborators of Shoichiro Ohta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoichiro Ohta. Shoichiro Ohta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel assay for improved detection of sputum periostin in patients with asthma 2023 ·PLoS ONE ·Junya Ono, (unknown), (unknown), Shoichiro Ohta, Parameswaran Nair, Kenji Izuhara, Sven‐Erik Dahlén, Anna James	5
2	Febuxostat Attenuates the Induction of Vascular Cell Adhesion Protein 1 by TNF-α in Human Umbilical Vein Endothelial Cells 2020 ·Pharmacology ·Yasuhiro Suzuki, (unknown), (unknown), (unknown), Shoichiro Ohta	3
3	Pirfenidone Improves Familial Idiopathic Pulmonary Fibrosis without Affecting Serum Periostin Levels 2019 ·Medicina ·Yasuhiko Koga, (unknown), Hiroaki Tsurumaki, Masakiyo Yatomi, Kyoichi Kaira, Shoichiro Ohta, Junya Ono, Kenji Izuhara, Kunio Dobashi, Takeshi Hisada	4
4	Periostin as a predictor of prognosis in chronic bird-related hypersensitivity pneumonitis 2019 ·Allergology International ·(unknown), Yasunari Miyazaki, (unknown), Tsukasa Okamoto, Haruhiko Furusawa, Tomoya Tateishi, Mitsuhiro Kishino, Ukihide Tateishi, Junya Ono, Shoichiro Ohta, Kenji Izuhara, Naohiko Inase	18
5	Squamous Cell Carcinoma Antigen 2 (SCCA2, SERPINB4): An Emerging Biomarker for Skin Inflammatory Diseases 2018 ·International Journal of Molecular Sciences ·Kenji Izuhara, Yukie Yamaguchi, Shoichiro Ohta, Satoshi Nunomura, Yasuhiro Nanri, Yoshinori Azuma, Noriko Nomura, Yasuhiko Noguchi, Michiko Aihara	41
6	Serum levels of squamous cell carcinoma antigens 1 and 2 reflect disease severity and clinical type of atopic dermatitis in adult patients 2017 ·Allergology International ·(unknown), Yukie Yamaguchi, (unknown), Junya Ono, Yoshinori Azuma, Noriko Komitsu, Yusuke Inoue, (unknown), Setsuko Matsukura, Takeshi Kambara, Shoichiro Ohta, Kenji Izuhara, Michiko Aihara	23
7	Updated recommendation on molecular-targeted therapy for metastatic renal cell cancer 2017 ·Molecular and Clinical Oncology ·Senji Hoshi, (unknown), (unknown), Masahiko Sato, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Katsuyuki Taguchi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Isoji Sasagawa, Shoichiro Ohta	0
8	The usefulness of measuring tear periostin for the diagnosis and management of ocular allergic diseases 2016 ·Journal of Allergy and Clinical Immunology ·Hiroshi Fujishima, Naoko Okada, Kenji Matsumoto, Kazumi Fukagawa, Ayako Igarashi, Akio Matsuda, Junya Ono, Shoichiro Ohta, Hideki Mukai, Mamoru Yoshikawa, Kenji Izuhara	38
9	Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease 2015 ·American Journal of Respiratory and Critical Care Medicine ·Anna James, Lovisa E. Reinius, Marri Verhoek, Anna Raquel Silveira Gomes, Maciej Kupczyk, Ulf Hammar, Junya Ono, Shoichiro Ohta, Kenji Izuhara, Elisabeth H. Bel, Juha Kere, Cilla Söderhäll, Barbro Dahlén, Rolf G. Boot, Sven‐Erik Dahlén	89
10	Recent developments regarding periostin in bronchial asthma 2015 ·Allergology International ·Kenji Izuhara, Hisako Matsumoto, Shoichiro Ohta, Junya Ono, Kazuhiko Arima, Masahiro Ogawa	48
11	Osteopontin and periostin in bronchial tissue associate with a 20-year decline of pulmonary function in asthmatics 2014 ·European Respiratory Journal ·Yoshihiro Kanemitsu, Isao Ito, Akio Niimi, Kenji Izuhara, Shoichiro Ohta, Junya Ono, Toshiyuki Iwata, Tsuyoshi Oguma, Tomoko Tajiri, Tadao Nagasaki, Yumi Izuhara, Hisako Matsumoto, Michiaki Mishima	1
12	Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma 2014 ·European Respiratory Journal ·Hitasha Rupani, Laurie Lau, Junya Ono, Shoichiro Ohta, Clair Barber, (unknown), Thomas Brown, Ramesh Kurukulaaratchy, Anoop Chauhan, Kenji Izuhara, Peter Howarth	2
13	Remarkable Response to Neoadjuvant Therapy with Methotrexate, Vinblastine, Adriamycin, and Cisplatin for Undifferentiated Bladder Carcinoma: A Case Report and Literature Review 2014 ·Case Reports in Oncology ·(unknown), Senji Hoshi, (unknown), (unknown), (unknown), Isoji Sasagawa, Shoichiro Ohta	1
14	Periostin, a Matricellular Protein, Plays a Role in the Induction of Chemokines in Pulmonary Fibrosis 2012 ·American Journal of Respiratory Cell and Molecular Biology ·Masaru Uchida, Hiroshi Shiraishi, Shoichiro Ohta, Kazuhiko Arima, Kazuto Taniguchi, Shoichi Suzuki, Masaki Okamoto, Shawn K. Ahlfeld, Koichi Ohshima, Seiya Kato, Shuji Toda, Hironori Sagara, Hisamichi Aizawa, Tomoaki Hoshino, Simon J. Conway, Shinichiro Hayashi, Kenji Izuhara	139
15	Host Inactivation of Bacterial Lipopolysaccharide Prevents Prolonged Tolerance Following Gram-Negative Bacterial Infection 2008 ·Cell Host & Microbe ·Mingfang Lu, Alan W. Varley, Shoichiro Ohta, (unknown), Robert S. Munford	67
16	Identification of a novel isoform of MD-2 that downregulates lipopolysaccharide signaling 2004 ·Biochemical and Biophysical Research Communications ·Shoichiro Ohta, Uleng Bahrun, Mariko Tanaka, Masao Kimoto	24
17	DNA MICROARRAY ANALYSIS OF GENES INVOLVED IN THE PROCESS OF DIFFERENTIATION IN MOUSE LEYDIG CELL LINE TTE1 2002 ·Archives of Andrology ·Shoichiro Ohta, Hideki Fuse, Yoshiaki Tabuchi	7
18	Differential Display Cloning of a Novel Rat cDNA (RNB6) That Shows High Expression in the Neonatal Brain Revealed a Member of Ena/VASP Family 1997 ·Biochemical and Biophysical Research Communications ·Shoichiro Ohta, Toshihiro Mineta, Masao Kimoto, Kazuo Tabuchi	9
19	Smaller Isoform of Human Mitochondrial Transcription Factor 1: Its Wide Distribution and Production by Alternative Splicing 1993 ·Biochemical and Biophysical Research Communications ·Kei Tominaga, J Hayashi, Y Kagawa, Shoichiro Ohta	22
20	Alterations in respiratory function and hemodynamics during laparoscopic cholecystectomy under pneumoperitoneum 1993 ·Surgical Endoscopy ·Kaoru Kubota, (unknown), (unknown), (unknown), (unknown), Shoichiro Ohta, (unknown), Shinichi Arizono	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact